Barclays starts coverage with USD 10 target for Senseonics stock

Published on 10/08/2026 at 20:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 14.48 million. Senseonics stock was EUR 8.05 on October 8, 2026, down 3.01 percent versus its prior close.

Key points in brief

Barclays began coverage of Senseonics on October 7, 2026, with an equal weight rating and a USD 10.00 price target.
Senseonics reported USD 14.48 million in second-quarter 2026 revenue and a GAAP net loss of USD 36.71 million.
The stock was trading at EUR 8.05 at Lang & Schwarz on October 8, 2026 at 8:35 p.m. CEST, down 3.01 percent versus the prior close.

SENS, US81727U3032, Illustration mit AI erstellt.

Senseonics stock (ISIN US81727U3032) was trading at EUR 8.05 at Lang & Schwarz on October 8, 2026 at 8:35 p.m. CEST in after-hours trading, down 3.01 percent versus the prior close of EUR 8.30. On October 7, 2026, Barclays began coverage with an equal weight rating and a USD 10.00 price target, according to MarketBeat.

Barclays sets a USD 10 marker

The new target puts Barclays' published valuation below the broader analyst reference cited by MarketBeat. Six analysts carried a consensus target of USD 13.00 and a Hold rating in the October 7 report, giving investors a clear gap between the latest single-house view and the wider consensus.

What does the target imply?

The operating backdrop remains mixed. Senseonics generated USD 14.48 million in revenue in the second quarter of 2026 and posted a GAAP net loss of USD 36.71 million, while the consensus loss was USD 31.99 million, according to MarketBeat. Revenue increased from USD 6.65 million in the comparable quarter, but the loss remains the central counterweight to the target discussion.

Three dated signals for SENS

On August 6, 2026, Senseonics reported second-quarter revenue of USD 14.48 million and a GAAP loss of USD 36.71 million, according to MarketBeat. On September 14, 2026, Senseonics announced a partnership with Beta Bionics to integrate Eversense 365 with the iLet Bionic Pancreas, with commercial launch planned after development in the fourth quarter of 2026, according to Senseonics. On October 7, 2026, Barclays set its equal weight rating and USD 10.00 target, according to Markets Insider.

Next earnings date is November 10

The next earnings date is November 10, 2026, according to Makkler. On Nasdaq, SENS was trading at USD 8.99 at 2:38 p.m. EDT on October 8, 2026, while its 52-week range stood at USD 4.79 to USD 10.64.

SENS trades below its prior close

At Lang & Schwarz, Senseonics was trading at EUR 8.05 on October 8, 2026 at 8:35 p.m. CEST in after-hours trading, down 3.01 percent versus the prior close of EUR 8.30. The further course of trading is shown by the continuously updated real-time quote of Senseonics stock.